Matinas BioPharma Holdings Inc (MTNB)
0.1749
-0.01
(-4.58%)
USD |
NYAM |
May 03, 16:00
0.1749
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Market Cap: 38.04M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 03, 2024 | 38.04M |
May 02, 2024 | 39.86M |
May 01, 2024 | 39.71M |
April 30, 2024 | 40.39M |
April 29, 2024 | 39.91M |
April 26, 2024 | 38.91M |
April 25, 2024 | 39.47M |
April 24, 2024 | 39.54M |
April 23, 2024 | 39.47M |
April 22, 2024 | 39.15M |
April 19, 2024 | 40.82M |
April 18, 2024 | 41.32M |
April 17, 2024 | 41.76M |
April 16, 2024 | 43.47M |
April 15, 2024 | 44.04M |
April 12, 2024 | 44.19M |
April 11, 2024 | 43.87M |
April 10, 2024 | 45.45M |
April 09, 2024 | 46.30M |
April 08, 2024 | 45.45M |
April 05, 2024 | 46.28M |
April 04, 2024 | 47.72M |
April 03, 2024 | 49.48M |
April 02, 2024 | 76.12M |
April 01, 2024 | 80.43M |
Date | Value |
---|---|
March 28, 2024 | 58.94M |
March 27, 2024 | 63.05M |
March 26, 2024 | 62.13M |
March 25, 2024 | 63.11M |
March 22, 2024 | 60.46M |
March 21, 2024 | 57.89M |
March 20, 2024 | 62.64M |
March 19, 2024 | 61.72M |
March 18, 2024 | 59.26M |
March 15, 2024 | 65.18M |
March 14, 2024 | 51.73M |
March 13, 2024 | 55.40M |
March 12, 2024 | 56.49M |
March 11, 2024 | 58.88M |
March 08, 2024 | 58.66M |
March 07, 2024 | 56.27M |
March 06, 2024 | 56.47M |
March 05, 2024 | 57.31M |
March 04, 2024 | 58.47M |
March 01, 2024 | 63.29M |
February 29, 2024 | 60.86M |
February 28, 2024 | 59.31M |
February 27, 2024 | 58.14M |
February 26, 2024 | 58.44M |
February 23, 2024 | 52.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
26.64M
Minimum
Oct 03 2023
376.89M
Maximum
Jan 02 2020
149.35M
Average
151.81M
Median
Mar 18 2022
Market Cap Benchmarks
NovaBay Pharmaceuticals Inc | 2.856M |
Palatin Technologies Inc | 34.05M |
iBio Inc | 6.934M |
Theriva Biologics Inc | 6.911M |
Oragenics Inc | 4.794M |
Market Cap Related Metrics
PS Ratio | 8.868 |
Price to Book Value | 1.976 |
Price | 0.1749 |
Earnings Yield | -68.61% |